References
- Schoen FJ, Levy RJ, Piehler HR. Pathological considerations in replacement cardiac valves. Cardiovasc Pathol 1992;1:29-52. https://doi.org/10.1016/1054-8807(92)90006-A
- Grunkemeier GL, Jamieson WRE, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg 1994;108:709-18.
- Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1993;113:143-55.
- Paul H, Peter Z. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 2001;71:S385. https://doi.org/10.1016/S0003-4975(01)02492-4
- Levy RJ, Qu X, Underwood T, Trachy J, Schoen FJ. Calcification of valved aortic allografts in rats: effects of age, crosslinking, inhibitors. J Biomed Mater Res 1995;29:217-26. https://doi.org/10.1002/jbm.820290212
- Jorge-Herrero E, Fernandez P, Gutierrez M, Castillo-Olivares JL. Study of the calcification of bovine pericardium: analysis of the implication of lipids and proteoglycans. Biomaterials 1991;12:638-89.
- Thomas PJ, James AB, Barbara LC, Frederick JS, Gordon A, Robert JL. Controlled release of ethanehydroxy diphosphonate from polyurethane reservoirs to inhibit calcification of bovine pericardium used in bioprosthetic heart valves. Int J Pharm 1990;59:95-104. https://doi.org/10.1016/0378-5173(90)90083-G
- Webb CL, Nguyen NM, Schoen FJ, Levy RJ. Calcification of allograft aortic wall in a rat subdermal model: pathophysiology and inhibition by Al3+ and aminodiphosphonate preincubations. Am J Pathol 1992;141:487-96.
- Hirsch D, Drader J, Yhomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies. J Biomed Mater Res 1993;27:1477-84. https://doi.org/10.1002/jbm.820271203
- Chen W, Scheon FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde pretreated porcine bioprosthetic heart valves. Circulation 1994;90:323-9. https://doi.org/10.1161/01.CIR.90.1.323
- Nimni WN, Cheung D, Strates B. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res 1994;15:465-9.
- Chanda J. Anticalcification treatment of pericardial prostheses. Biomaterials 1994;15:465-9. https://doi.org/10.1016/0142-9612(94)90226-7
- Pereira CA, Lee JM, Haberer SA. Effect of alternative crosslinkingmethods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material. J Biomed Mater Res 1990;24:345-61. https://doi.org/10.1002/jbm.820240307
- Trantina-Yates AE, Humana P, Zilla P. Detoxication on top of enhanced, diamine-etended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in sheep model. J Heart Valve Disease 2003;12:93-101.
- Humana P, Bezuidenhouta D, Torriannib M, Hendriksc M, Zilla P. Optimization of diamine bridges in glutaraldehyde treated bioprosthetic aortic wall tissue. Biomaterials 2002;23:2099-103. https://doi.org/10.1016/S0142-9612(01)00302-7
- Lee CH, Vyavahare N, Zand R, et al. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res 1998;42:30-7. https://doi.org/10.1002/(SICI)1097-4636(199810)42:1<30::AID-JBM5>3.0.CO;2-P
- Neethling WM, Hodge AJ, Clode P, Glancy R. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium. J Cardiovasc Surg (Torino) 2006;47:711-8.
- Garcia Paez JM, Jorge-Herrero E, Carrera A, et al. Chemical treatment and tissue selection: factors that influence the mechanical behaviour of porcine pericardium. Biomaterials 2001;22:2759-67. https://doi.org/10.1016/S0142-9612(01)00019-9
- Kim KC, Choi YK, Kim SH, et al. Effect of diamine bridges using L-lysine in glutaraldehyde treated porcine pericardium. Korean J Thorac Cardiovasc Surg 2009;42:157-64.
- Jee KS, Kim YS, Park KD, Kim YH. A novel chemical modification of bioprosthetic tissues using L-arginine. Biomaterials 2003;24:3409-16. https://doi.org/10.1016/S0142-9612(03)00204-7
- Connolly JM, Alferiev I, Kronsteiner A, Lu Z, Levy RJ. Ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride. J Heart Valve Dis 2004;13:487-93.
- Cho SK, Kim YJ, Kim SH, et al. Comparison of the uniaxial tensile strength, elasticity and thermal stability between glutaraldehyde and glutaraldehyde with solvent fixation in xenograft cardiovascular tissue. Korean J Thorac Cardiovasc Surg 2009;42:165-74.
Cited by
- The angiotensin II type 1 receptor blocker losartan attenuates bioprosthetic valve leaflet calcification in a rabbit intravascular implant model vol.50, pp.6, 2011, https://doi.org/10.1093/ejcts/ezw191
- Optimizing Glutaraldehyde-Fixed Tissue Heart Valves with Chondroitin Sulfate Hydrogel for Endothelialization and Shielding against Deterioration vol.19, pp.4, 2018, https://doi.org/10.1021/acs.biomac.8b00077
- In vivo evaluation of Vivere bovine pericardium valvular bioprosthesis with a new anti‐calcifying treatment vol.44, pp.11, 2011, https://doi.org/10.1111/aor.13718
- Nonglutaraldehyde crosslinked bioprosthetic heart valves based on 2-isocyanatoethyl methacrylate crosslinked porcine pericardium with improved properties of stability, cytocompatibility and anti-calci vol.230, pp.None, 2022, https://doi.org/10.1016/j.compositesb.2021.109504